Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Dlouhy I, Armengol M, Recasens-Zorzo C, Ribeiro ML, Pérez-Galán P, Bosch F, López-Guillermo A, Roué G. Dlouhy I, et al. Among authors: ribeiro ml. Haematologica. 2021 Oct 1;106(10):2749-2753. doi: 10.3324/haematol.2020.278258. Haematologica. 2021. PMID: 33979991 Free PMC article. No abstract available.
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Dlouhy I, Armengol M, Recasens-Zorzo C, Ribeiro ML, Pérez-Galán P, Bosch F, López-Guillermo A, Roué G. Dlouhy I, et al. Among authors: ribeiro ml. Haematologica. 2022 Dec 1;107(12):2990. doi: 10.3324/haematol.2022.281988. Haematologica. 2022. PMID: 36453521 Free PMC article. No abstract available.
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy.
Ribeiro ML, Profitós-Pelejà N, Santos JC, Blecua P, Reyes-Garau D, Armengol M, Fernández-Serrano M, Miskin HP, Bosch F, Esteller M, Normant E, Roué G. Ribeiro ML, et al. Front Immunol. 2023 Apr 21;14:1130052. doi: 10.3389/fimmu.2023.1130052. eCollection 2023. Front Immunol. 2023. PMID: 37153563 Free PMC article.
Epigenetic targets in B- and T-cell lymphomas: latest developments.
Ribeiro ML, Sánchez Vinces S, Mondragon L, Roué G. Ribeiro ML, et al. Ther Adv Hematol. 2023 May 30;14:20406207231173485. doi: 10.1177/20406207231173485. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37273421 Free PMC article. Review.
Characterization of central-involved diabetic macular edema using OCT and OCTA.
Reste-Ferreira D, Santos T, Marques IP, Ribeiro ML, Santos AR, Martinho AC, Lobo C, Cunha-Vaz J. Reste-Ferreira D, et al. Among authors: ribeiro ml. Eur J Ophthalmol. 2024 Apr 22:11206721241248478. doi: 10.1177/11206721241248478. Online ahead of print. Eur J Ophthalmol. 2024. PMID: 38644796
337 results